UBS Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.26M | Sell |
31,048
-12,230
| -28% | -$496K | ﹤0.01% | 4175 |
|
2025
Q1 | $1.9M | Sell |
43,278
-4,298
| -9% | -$188K | ﹤0.01% | 3735 |
|
2024
Q4 | $2.05M | Buy |
47,576
+7,432
| +19% | +$320K | ﹤0.01% | 3697 |
|
2024
Q3 | $1.78M | Buy |
40,144
+1,345
| +3% | +$59.7K | ﹤0.01% | 3137 |
|
2024
Q2 | $1.54M | Sell |
38,799
-2,386
| -6% | -$94.9K | ﹤0.01% | 3061 |
|
2024
Q1 | $1.78M | Sell |
41,185
-668
| -2% | -$28.8K | ﹤0.01% | 3076 |
|
2023
Q4 | $1.74M | Buy |
41,853
+18,857
| +82% | +$785K | ﹤0.01% | 2981 |
|
2023
Q3 | $914K | Sell |
22,996
-877
| -4% | -$34.9K | ﹤0.01% | 3156 |
|
2023
Q2 | $979K | Sell |
23,873
-687
| -3% | -$28.2K | ﹤0.01% | 3330 |
|
2023
Q1 | $1.01M | Sell |
24,560
-498,422
| -95% | -$20.4M | ﹤0.01% | 3167 |
|
2022
Q4 | $21.4M | Buy |
522,982
+120,085
| +30% | +$4.92M | 0.01% | 962 |
|
2022
Q3 | $16.2M | Sell |
402,897
-33,352
| -8% | -$1.34M | 0.01% | 1022 |
|
2022
Q2 | $18.3M | Buy |
436,249
+405,089
| +1,300% | +$17M | 0.01% | 1009 |
|
2022
Q1 | $1.41M | Buy |
31,160
+2,438
| +8% | +$110K | ﹤0.01% | 2941 |
|
2021
Q4 | $1.33M | Buy |
28,722
+618
| +2% | +$28.5K | ﹤0.01% | 3227 |
|
2021
Q3 | $1.33M | Sell |
28,104
-741
| -3% | -$35.1K | ﹤0.01% | 3038 |
|
2021
Q2 | $1.49M | Sell |
28,845
-765
| -3% | -$39.6K | ﹤0.01% | 2953 |
|
2021
Q1 | $1.49M | Sell |
29,610
-312
| -1% | -$15.7K | ﹤0.01% | 3014 |
|
2020
Q4 | $1.56M | Sell |
29,922
-1,150
| -4% | -$59.9K | ﹤0.01% | 2821 |
|
2020
Q3 | $1.35M | Buy |
31,072
+1,874
| +6% | +$81.5K | ﹤0.01% | 2727 |
|
2020
Q2 | $1.26M | Sell |
29,198
-9
| -0% | -$387 | ﹤0.01% | 2640 |
|
2020
Q1 | $1.05M | Sell |
29,207
-2,609
| -8% | -$94.2K | ﹤0.01% | 2617 |
|
2019
Q4 | $1.45M | Buy |
31,816
+824
| +3% | +$37.6K | ﹤0.01% | 3029 |
|
2019
Q3 | $1.1M | Sell |
30,992
-2,862
| -8% | -$102K | ﹤0.01% | 3126 |
|
2019
Q2 | $1.35M | Sell |
33,854
-380
| -1% | -$15.1K | ﹤0.01% | 2811 |
|
2019
Q1 | $1.42M | Sell |
34,234
-16,031
| -32% | -$666K | ﹤0.01% | 2679 |
|
2018
Q4 | $1.84M | Sell |
50,265
-87,452
| -64% | -$3.2M | ﹤0.01% | 2513 |
|
2018
Q3 | $6.69M | Buy |
137,717
+64,386
| +88% | +$3.13M | ﹤0.01% | 1674 |
|
2018
Q2 | $3.15M | Sell |
73,331
-6,810
| -8% | -$293K | ﹤0.01% | 2204 |
|
2018
Q1 | $3.36M | Sell |
80,141
-51,626
| -39% | -$2.16M | ﹤0.01% | 2164 |
|
2017
Q4 | $5.73M | Sell |
131,767
-17,763
| -12% | -$773K | ﹤0.01% | 1737 |
|
2017
Q3 | $6.36M | Sell |
149,530
-93,821
| -39% | -$3.99M | ﹤0.01% | 1571 |
|
2017
Q2 | $10.5M | Sell |
243,351
-197,335
| -45% | -$8.49M | 0.01% | 1175 |
|
2017
Q1 | $18.4M | Sell |
440,686
-193,525
| -31% | -$8.1M | 0.01% | 845 |
|
2016
Q4 | $24.8M | Buy |
634,211
+197,181
| +45% | +$7.71M | 0.01% | 674 |
|
2016
Q3 | $19.3M | Buy |
437,030
+213
| +0% | +$9.41K | 0.01% | 770 |
|
2016
Q2 | $18.3M | Sell |
436,817
-28,021
| -6% | -$1.17M | 0.01% | 758 |
|
2016
Q1 | $18.7M | Sell |
464,838
-88,540
| -16% | -$3.56M | 0.01% | 733 |
|
2015
Q4 | $28.3M | Buy |
553,378
+99,675
| +22% | +$5.1M | 0.02% | 601 |
|
2015
Q3 | $21.3M | Buy |
453,703
+265,565
| +141% | +$12.5M | 0.02% | 673 |
|
2015
Q2 | $11.7M | Sell |
188,138
-299,058
| -61% | -$18.6M | 0.01% | 1054 |
|
2015
Q1 | $30.1M | Sell |
487,196
-207,674
| -30% | -$12.8M | 0.02% | 592 |
|
2014
Q4 | $37.5M | Buy |
+694,870
| New | +$37.5M | 0.03% | 525 |
|